Pharmacophore development, drug-likeness analysis, molecular docking, and molecular dynamics simulations for identification of new CK2 inhibitors
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pharmacophore development, drug-likeness analysis, molecular docking, and molecular dynamics simulations for identification of new CK2 inhibitors
Authors
Keywords
-
Journal
JOURNAL OF MOLECULAR MODELING
Volume 26, Issue 6, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-05-29
DOI
10.1007/s00894-020-04408-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Computer-aided identification of lead compounds as Cyclooxygenase-2 inhibitors using virtual screening and molecular dynamic simulation
- (2018) Mourad Ounissi et al. COMPUTATIONAL BIOLOGY AND CHEMISTRY
- Dihydrobenzo[4,5]imidazo[1,2-a]pyrimidine-4-ones as a new class of CK2 inhibitors
- (2018) Mykola V. Protopopov et al. MOLECULAR DIVERSITY
- Synthesis, characterization, theoretical studies, ADMET and drug-Likeness analysis: Electrochemical and biological activities of metal complexes of 3-(2-hydroxybenzoyl)-2H-chromen-2-one
- (2018) Drifa Belkhir-Talbi et al. JOURNAL OF MOLECULAR STRUCTURE
- Green synthesis, antioxidant and antibacterial activities of 4-aryl-3,4-dihydropyrimidinones/thiones derivatives of curcumin. Theoretical calculations and mechanism study
- (2018) Nassima Khaldi-Khellafi et al. JOURNAL OF MOLECULAR STRUCTURE
- Identification of dual kinase inhibitors of CK2 and GSK3β: combined qualitative and quantitative pharmacophore modeling approach
- (2017) Triveni Pardhi et al. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
- Identification of Novel Inhibitors of Leishmania donovani γ-Glutamylcysteine Synthetase Using Structure-Based Virtual Screening, Docking, Molecular Dynamics Simulation, and in Vitro Studies
- (2017) Pragati Agnihotri et al. Journal of Chemical Information and Modeling
- Identification of new potential HIV-1 reverse transcriptase inhibitors by QSAR modeling and structure-based virtual screening
- (2017) Fereshteh Shiri et al. JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION
- Structure based in silico identification of potentially non-steroidal brassinosteroids mimics
- (2017) Beilei Lei et al. Molecular BioSystems
- ProTox: a web server for the in silico prediction of rodent oral toxicity
- (2014) Malgorzata N. Drwal et al. NUCLEIC ACIDS RESEARCH
- Discovery and characterization of synthetic 4′-hydroxyflavones—New CK2 inhibitors from flavone family
- (2013) Andriy G. Golub et al. BIOORGANIC & MEDICINAL CHEMISTRY
- New substituted benzimidazole derivatives: a patent review (2010 – 2012)
- (2013) Fan Fei et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Design, synthesis and evaluation of 2-phenylisothiazolidin-3-one-1,1-dioxides as a new class of human protein kinase CK2 inhibitors
- (2013) Maksym O. Chekanov et al. JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY
- Inhibition of Protein Kinase CK2 by Flavonoids and Tyrphostins. A Structural Insight
- (2012) Graziano Lolli et al. BIOCHEMISTRY
- DecoyFinder: an easy-to-use python GUI application for building target-specific decoy sets
- (2012) Adrià Cereto-Massagué et al. BIOINFORMATICS
- Identification of Novel β3-Adrenoceptor Agonists Using Energetic Analysis, Structure Based Pharmacophores and Virtual Screening
- (2012) Parul Tewatia et al. COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING
- Protein kinase CK2 inhibitors: a patent review
- (2012) Giorgio Cozza et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- ZINC: A Free Tool to Discover Chemistry for Biology
- (2012) John J. Irwin et al. Journal of Chemical Information and Modeling
- Identification of CK2 inhibitors with new scaffolds by a hybrid virtual screening approach based on Bayesian model; pharmacophore hypothesis and molecular docking
- (2012) Lei Di-wu et al. JOURNAL OF MOLECULAR GRAPHICS & MODELLING
- Receptor and ligand-based 3D-QSAR study on a series of nonsteroidal anti-inflammatory drugs
- (2012) Souhila Bouaziz-Terrachet et al. MEDICINAL CHEMISTRY RESEARCH
- Quantifying the chemical beauty of drugs
- (2012) G. Richard Bickerton et al. Nature Chemistry
- Structural Determinants of CX-4945 Derivatives as Protein Kinase CK2 Inhibitors: A Computational Study
- (2011) Hongbo Liu et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- A detailed thermodynamic profile of cyclopentyl and isopropyl derivatives binding to CK2 kinase
- (2011) Takayoshi Kinoshita et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Pre-clinical characterization of CX-4945, a potent and selective small molecule inhibitor of CK2 for the treatment of cancer
- (2011) Fabrice Pierre et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Structure-Based Pharmacophore Modeling from Multicomplex: a Comprehensive Pharmacophore Generation of Protein Kinase CK2 and Virtual Screening Based on it for Novel Inhibitors
- (2011) Hao-Peng Sun et al. Molecular Informatics
- CX-4945, an Orally Bioavailable Selective Inhibitor of Protein Kinase CK2, Inhibits Prosurvival and Angiogenic Signaling and Exhibits Antitumor Efficacy
- (2010) A. Siddiqui-Jain et al. CANCER RESEARCH
- Pharmacophore modeling and applications in drug discovery: challenges and recent advances
- (2010) Sheng-Yong Yang DRUG DISCOVERY TODAY
- Modeling the binding modes of stilbene analogs to cyclooxygenase-2: a molecular docking study
- (2010) Souhila Bouaziz-Terrachet et al. JOURNAL OF MOLECULAR MODELING
- Structure-based discovery of small molecules targeting different surfaces of protein-kinase CK2
- (2009) Renaud Prudent et al. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS
- Pharmacophore Identification and Validation Study of CK2 Inhibitors Using CoMFA/CoMSIA
- (2009) Mohammad Neaz Morshed et al. Chemical Biology & Drug Design
- The CK2α/CK2β Interface of Human Protein Kinase CK2 Harbors a Binding Pocket for Small Molecules
- (2008) Jennifer Raaf et al. CHEMISTRY & BIOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started